A Phase 2 Trial Testing ZP1848 in Patients With SBS
Phase of Trial: Phase II
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Glepaglutide (Primary)
- Indications Short bowel syndrome
- Focus Proof of concept; Therapeutic Use
- Sponsors Zealand Pharma
- 07 Mar 2018 According to a Zealand Pharma media release, data from the trial was presented at the ASPEN conference 2018.
- 23 Jan 2018 According to a Zealand Pharma media release, more detailed results from the trial focusing on micro- and macronutrients, intestinal morphology and intestinal transit time will be presented at further scientific conferences in 2018.
- 23 Jan 2018 Results published in a Zealand Pharma Media Release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History